Cytomegalovirus glomerulopathy: a controversial lesion

Area of Science:

• Nephrology
• Virology
• Transplant Immunology

Background:

• Cytomegalovirus (CMV) infection is a significant concern in immunosuppressed individuals, particularly kidney transplant recipients.
• The entity known as CMV glomerulopathy has been described, but its pathological basis remains debated.

Observation:

• Autopsies of immunosuppressed bone marrow transplant recipients with CMV infection showed no kidney pathology.
• Renal biopsies from kidney transplant recipients with suspected CMV infection revealed endothelial cell damage but lacked definitive CMV evidence.
• Disseminated CMV infection in children and CMV infection in kidney transplant recipients did not demonstrate glomerulopathy.

Findings:

• No evidence of glomerulopathy or specific kidney damage was found in relation to cytomegalovirus infection across multiple patient groups.
• Pathological findings in suspected CMV glomerulopathy cases were more consistent with various forms of kidney transplant rejection, including anti-endothelial or resolved acute vascular rejection.

Implications:

• The diagnosis of CMV glomerulopathy should be reconsidered, as observed kidney damage is likely attributable to transplant rejection mechanisms.
• This re-evaluation impacts diagnostic criteria and treatment strategies for kidney transplant recipients presenting with renal dysfunction and suspected viral infections.
• Further research is needed to differentiate between viral-induced damage and rejection in transplant nephropathy.